Académique Documents
Professionnel Documents
Culture Documents
CLASSIFICATION
Mezangioproliferativny glomerulonephritis.
ETIOLOGY
The cause of the disease can not be established in all cases. Nefritogennyh suggest the
role of streptococcal strains, persistent viruses (hepatitis B, cytomegalovirus,
Coxsackie virus, Epstein-Barr virus, influenza, etc.), genetically determined
characteristics of immunity (eg, a defect in the complement system or cellular
immunity ).Emergence of the disease contribute to congenital renal dysplasia.
PATHOGENESIS
Clinical picture
Nephrotic form
Gematuricheskaya form
The main manifestation of this form - persistent hematuria. Possible slight proteinuria
and anemia. The state of health of patients is usually not disturbed. In some cases,
mark pastoznost century. Morphologically this mezangioproliferativny
glomerulonephritis (a version with the deposition in the glomeruli of IgA and
complement component E).
Mixed form
Develops in older children and has a heavy and steadily progressive course, torpid to
therapy. When mixed form of all possible morphological variants (except for minimal
changes). Most often reveal mezangiokapillyarny variant characterized by
proliferation of mesangial cells and thickening or dvukonturnostyu capillary walls due
to infiltration of mesangial cells. Progress-tion of the pathological process leads to the
development of sclerosis and the formation of fibroplasticheskogo glomerulonephritis
- the finale of most forms of chronic glomerulonephritis. Sclerosis developed capillary
loops glomerulus, formed fibroepitelialnye and fibrous crescents, sclerosis and
thickening of the capsule body.
The disease often begins with an acute nephrotic syndrome with sudden development
of hematuria, severe non-selective proteinuria, edema and persistent
hypertension. The disease can rapidly increasing renal insufficiency. The peculiarity
of the mixed form - gipokomplementemiya with reduced concentrations of NE and /
or C4 components of complement. Prognosis is poor quite quickly in children
developing chronic renal failure.
TREATMENT
At the present stage, consider the optimal treatment in the light of morphological
variants of chronic glomerulonephritis, but it is not always possible, especially in
children, and you have to focus on the clinical manifestations of disease. The
treatment prescribed depending on the activity of the pathological process. In the
active period of the disease in the presence of edema, gross hematuria and blood
pressure shows a pronounced increase bed rest. He expanded the fading of clinical
manifestations of pathological process. Diet prescribed given the state
azotovydelitelnoy kidney function. With its secure child gets protein in an amount
corresponding to the age norm (2-3 g / kg / day), with azotemia - 1 g / kg / day.
Pronounced hyperlipidemia need to reduce intake of fats. When edema and
hypertension appoint gipohloridnuyu diet. The volume of fluid dose out depending on
diuresis. However, under polyuria such restrictions are unnecessary and even harmful.
In view of the pathogenesis of glomerulonephritis used drugs that affect both the
immune mechanisms (glucocorticoids, cytotoxic agents), and in non-immune [anti-
coagulants (heparin at 200-400 U / kg / day for 2-4 weeks or more), antiagreganty
(dipyridamole and 3 -5 mg / kg), ACE inhibitors (enalapril, lisinopril)], as prescribed
lipid-lowering drugs [lovastatin, fluvastatin (leskol) and others].
When first mooted nephrotic syndrome with minimal change glomerular recommend
starting treatment with prednisolone at a dose of 2-3 mg / kg body weight or 60 mg /
m 2. The drug in this dose prescribed for 4-8 weeks. In nephrotic syndrome, sensitive
to hormonal therapy (most children), there comes a clinical and laboratory
remission.Relapse, which developed after the abolition of glucocorticoids suggests
hormonal dependence of nephrotic syndrome. Treatment of first relapse of conduct as
well as therapy in early disease. With frequent relapses adding cytotoxic agents -
cyclophosphamide 2 mg / kg chlorambucil (leykeran, hlorbutin) of 0,1-0,2 mg / kg,
while reducing the dose of prednisolone to 40 mg / m 2 and transferring the patient to
the alternating mode of administration of the drug (one day). Lack of effect of
hormone replacement therapy for 8 weeks indicate nephrotic syndrome resistant to
hormonal therapy. In this case, treatment is carried out selective cytostatics or
immunosuppressants cyclosporine at a dose of 3-5 mg / kg.
Patients with focal segmental glomerular sclerosis in the present long-term courses
(up to 6 months) designate glucocorticoids and cytotoxic agents, to achieve remission
in patients previously judged unsuitable.
PREVENTION
FORECAST